Atb Cap Markets Comments on Aurora Cannabis FY2028 Earnings

Aurora Cannabis Inc. (NASDAQ:ACB) – Investment analysts at Atb Cap Markets dropped their FY2028 earnings estimates for Aurora Cannabis in a report released on Wednesday, November 5th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of $0.07 per share for the year, down from their prior forecast of $0.15. The consensus estimate for Aurora Cannabis’ current full-year earnings is $0.46 per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ FY2029 earnings at $0.29 EPS.

Aurora Cannabis (NASDAQ:ACB) last announced its earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.06. The firm had revenue of $64.88 million for the quarter, compared to analyst estimates of $86.45 million. Aurora Cannabis had a negative net margin of 15.96% and a negative return on equity of 0.58%.

Several other equities analysts also recently weighed in on ACB. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aurora Cannabis in a research report on Wednesday, October 8th. Zacks Research upgraded Aurora Cannabis from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Finally, Wall Street Zen lowered shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a report on Friday, July 18th. Two investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Aurora Cannabis currently has an average rating of “Moderate Buy”.

Aurora Cannabis Trading Up 4.4%

Shares of Aurora Cannabis stock opened at $4.55 on Friday. The firm has a market cap of $255.80 million, a PE ratio of -6.59 and a beta of 1.71. The company has a quick ratio of 1.51, a current ratio of 3.41 and a debt-to-equity ratio of 0.06. Aurora Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $6.91. The business’s fifty day moving average is $5.19 and its two-hundred day moving average is $5.01.

Institutional Trading of Aurora Cannabis

A number of institutional investors have recently modified their holdings of ACB. Cubist Systematic Strategies LLC increased its position in Aurora Cannabis by 358.6% during the 1st quarter. Cubist Systematic Strategies LLC now owns 238,460 shares of the company’s stock worth $1,047,000 after purchasing an additional 186,462 shares in the last quarter. AdvisorShares Investments LLC increased its holdings in Aurora Cannabis by 277.9% in the 3rd quarter. AdvisorShares Investments LLC now owns 190,380 shares of the company’s stock valued at $1,135,000 after purchasing an additional 140,000 shares in the last quarter. Northwest & Ethical Investments L.P. purchased a new position in Aurora Cannabis in the first quarter valued at about $452,000. Tidal Investments LLC raised its position in Aurora Cannabis by 6.0% in the second quarter. Tidal Investments LLC now owns 1,509,483 shares of the company’s stock valued at $6,400,000 after purchasing an additional 86,045 shares during the period. Finally, Jones Financial Companies Lllp lifted its stake in shares of Aurora Cannabis by 9,615.6% during the first quarter. Jones Financial Companies Lllp now owns 52,270 shares of the company’s stock worth $229,000 after purchasing an additional 51,732 shares in the last quarter. Hedge funds and other institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.